Markets
5.0
SK Biopharm Q3 Operating Profit Surges 66% on U.S. Seizure Drug Sales
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateYonhap ENLow-rated sourceKR · US
MarketsReportedMediumDeveloping
4.8
AstraZeneca bids ~$9.7B for Rhythm Pharmaceuticals
AstraZeneca has made a multi-billion dollar bid for US-listed Rhythm Pharmaceuticals, per WSJ sources. The deal, if confirmed, would expand AstraZeneca's rare-disease portfolio. Financial terms and regulatory outlook remain uncertain.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Score Breakdown
Mosaic Score4.8
Model confidence0.5
Significance0.5
Source credibility0.3
Intelligence Tags
Entities
United StatescountrySwedencountry
Related signals
8 foundHealth
4.7
Revolution Medicines' pancreatic cancer drug Rasonque posts record launch
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateSTAT NewsLow-rated sourceUS
Markets
2.1
Camurus holds SEK 4.4B cash; earmarks for launches, R&D, M&A
Published 1 d ago1 sourceEvidence: Reported
Dagens IndustriLow-rated sourceSE
Markets
2.1
BioNTech swings to Q3 profit, lifts 2026 revenue guidance
Published 2 d ago1 sourceEvidence: Reported
Anadolu Agency ENDE
Markets
2.0
AstraZeneca leads OMXS30 declines; European pharma sector weak
Published 3 h ago1 sourceEvidence: Reported
Dagens IndustriLow-rated sourceSE · GB
Conflict
9.4
Russian strikes cripple Ukraine drug supply chain, pharmacies empty
Published 1 d ago16 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyKyiv IndependentUA · RU
Markets
6.4
Novo Raises Full-Year Targets; Analyst Sees Gradual Turnaround
Published 1 d ago6 sourcesEvidence: Reported
SeverityModerateDagens IndustriLow-rated sourceSE
Markets
5.6
Novo Nordisk Q3 beats on Wegovy pill, but Eli Lilly lead persists
Published 1 d ago3 sourcesEvidence: Reported
SeverityModerateFDLow-rated sourceDK · US